Krystal Biotech buy Bank of America Co.
Start price
22.07.25
/
50%
€129.30
Target price
22.07.26
€164.24
Performance (%)
136.97%
Price
24.06.26
€306.40
Summary
This prediction is currently active. With a performance of 136.97% the BUY prediction by Bank_of_America_Co_ is a big success. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 2.992% | 2.992% |
| iShares Core DAX® | -0.318% | -0.464% |
| iShares Nasdaq 100 | -0.378% | 1.358% |
| iShares Nikkei 225® | -0.907% | 9.389% |
| iShares S&P 500 | 0.437% | 0.810% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Bank of America Corporation from $193.00 to $192.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€246.10
22.01.26
22.01.26
€272.02
22.01.27
22.01.27
24.50%
24.06.26
24.06.26
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
92.58%
24.06.26
24.06.26